Search alternatives:
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mm decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
point decrease » point increase (Expand Search)
fold decrease » fold increase (Expand Search), fold increased (Expand Search)
mm decrease » _ decrease (Expand Search), nn decrease (Expand Search), mean decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
8001
Comparison of position trajectories and truth values of different algorithms.
Published 2025Subjects: -
8002
Comparison of position trajectories and truth values of different algorithms.
Published 2025Subjects: -
8003
-
8004
-
8005
-
8006
-
8007
Positioning error results of different algorithms in the urban nav dataset.
Published 2025Subjects: -
8008
-
8009
Comparison of positioning results between different algorithms in two scenarios.
Published 2025Subjects: -
8010
-
8011
A sample choice question without a warning label.
Published 2024“…The random parameters logit model results showed a significant overall decrease in SSB purchases when a warning label was present, indicated by a significant negative coefficient associated with the label. …”
-
8012
-
8013
Rhodium Catalysts Based on Polyphenyl-Substituted Cp Ligands for Regioselective Annulation of Aryl Hydroxamates with Terminal Alkenes
Published 2025“…The use of the overloaded pentaphenylcyclopentadienyl ligand Cp<sup>Ph5</sup> or its less bulky pentabenzyl analog Cp<sup>Bn5</sup> resulted in a dramatic decrease in the efficiency or regioselectivity, respectively. …”
-
8014
-
8015
-
8016
-
8017
-
8018
-
8019
Atrial Anti-Arrhythmic Effects of Heptanol in Langendorff-Perfused Mouse Hearts - Fig 4
Published 2016“…<p>In the arrhythmic group, 2 mM heptanol increased activation latency (a, asterisks, ANOVA, <i>P</i> < 0.001, <i>n</i> = 9) and therefore decreased the corresponding CV (b; <i>P</i> < 0.01; <i>n</i> = 9) and increased atrial effective refractory period (AERP) (c, <i>P</i> < 0.001; <i>n</i> = 9) without altering APD<sub>90</sub> (d, <i>P</i> > 0.05, <i>n</i> = 5). …”
-
8020